Abstract
Inhibition of TRPC6 reduces systemic inflammation, cardiac fibrosis, and dramatically improves survival in dystrophic cardiomyopathy
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1016/j.yjmcc.2022.08.184
Copy DOIPublication Date: Dec 1, 2022 |
Inhibition of TRPC6 reduces systemic inflammation, cardiac fibrosis, and dramatically improves survival in dystrophic cardiomyopathy
Join us for a 30 min session where you can share your feedback and ask us any queries you have